Unlike Pep3 and Pep4, Pep2 exhibited its intrinsic efficacy on the absorption of doxorubicin only in the presence of levan and BC, not levan alone, suggesting that each peptide requires its appropriate stabilizer. The gene discussed is VPS18; the disease is breast cancer.